Drug Shortage Report for NOVO-HYDROXYZIN

Last updated on 2017-10-05 History
Report ID 159
Drug Identification Number 00738824
Brand name NOVO-HYDROXYZIN
Common or Proper name Hydroxyzine
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROXYZINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N05BB
ATC description ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-03-26
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-04-25 French Compare
v6 2017-04-25 English Compare
v5 2017-03-13 French Compare
v4 2017-03-13 English Compare
v3 2017-03-10 French Compare
v2 2017-03-10 English Compare
v1 2017-03-10 English Compare